# Empyema Treated With tPA & DNAse

> **NCT01862458** · PHASE3 · WITHDRAWN · sponsor: **Children's Mercy Hospital Kansas City**

## Conditions studied

- Empyema

## Interventions

- **BIOLOGICAL:** tPA alone
- **BIOLOGICAL:** tPA plus dornase

## Key facts

- **NCT ID:** NCT01862458
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding difficulty
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862458, "Empyema Treated With tPA & DNAse". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01862458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*